Introduction
Pulse rate is usually measured with blood pressure in patients undergoing chronic haemodialysis (HD). Both pulse Tachycardia as a predictor of poor survival in chronic haemodialysis patients 963 rate and blood pressure fluctuate in response to different measurement methods or under different measurement conditions, but are nevertheless usually considered reliable biometric markers for use in epidemiologic research. In contrast with blood pressure, the significance of pulse rate in dialysis patients is not well studied [1] [2] [3] . In the general population, several studies have reported an association between heart rate and cardiovascular morbidity or mortality [4] [5] [6] [7] and all-cause mortality [4, 5, 7] . Many of these epidemiologic studies have been cross-sectional in nature and derived from a large database. Cardiovascular disease is the leading cause of death, and tachycardia may be the underlying cause of cardiovascular morbidity in the HD population. Survival rate depends not only on tachycardia but also on other significant confounding variables such as nutritional status [8, 9] and chronic inflammation [10, 11] . Tachycardia in HD patients may be associated with a poor nutritional state and sympathetic overdrive, and hypotension may be associated with congestive heart failure and severe malnutrition [12] . The prevalent HD population is heterogeneous however, and the length of follow-up and type of complications differ; therefore, the association between pulse rate and mortality rate in HD patients has not been clarified.
The survival rate of Japanese HD patients is better than that in Europe and the USA [13] , but there are no certain reasons for this. Here, we examined a 1-year survival based on pre-HD pulse rate using the database of the Committee of Renal Data Registry of the Japanese Society for Dialysis Therapy (JSDT). To our knowledge, the present study is the largest national database study to date on the effect of pulse rate on survival in HD patients.
Materials and methods

The JSDT registry
The JSDT has been conducting an annual questionnaire survey of dialysis facilities throughout Japan since 1968, and several papers based on these surveys have been published [14, 15] . Since 1983, the JSDT has been compiling a computer-based registry. Details on the inception, limitations, validity, variables and questionnaires used in the study are available online at the JSDT homepage website, www.jsdt.or.jp. In brief, year-end survey questionnaires are sent to all dialysis facilities in Japan each year. The questionnaire comprises four pages, and the response rate for the first page is close to 100%. Questionnaires were administered by volunteers from among the staff of the facilities, the principal investigators in each prefecture, and the JSDT committee members. The JSDT funds a standing committee responsible for statistics and investigation. In addition to the regular questionnaire, new survey items are added each year. In 2005, new questions were added regarding the pulse rate, use of any anti-hypertensive drugs and the drug class, such as an angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, calcium channel blockers, etc. [16] . Renin-angiotensin system inhibitors include an angiotensinconverting enzyme inhibitor and/or angiotensin-converting enzyme inhibitor. Due to the limitations of the questionnaire, types of calcium channel blockers such as dihydropyridine and non-dihydropyridine were not surveyed. However, the history of acute myocardial infarction, cerebral haemorrhage, cerebral infarction and amputations of extremities was available.
A standard analysis file was prepared for the present study (JRDR-09112). Figure 1 summarizes the data extraction process. In the JSDT 2005 registry, a total of 257 765 dialysis patients were compiled, among which 248 211 (96.3%) of them were on chronic HD. Among the HD patients, 203 178 subjects were dialysed three times per week, and 54 121 were excluded due to incomplete pertinent clinical data including those with a pulse rate of <40 bpm (n = 64) and those with a pulse rate of 130 bpm and over (n = 188). We also excluded patients who were under the age of 20 years (n = 69) or over the age of 90 years (n = 1286) at the end of 2005.
Pulse rate and blood pressure were measured before the HD session, usually in a supine position and after the longest interval between HD sessions. Therefore, 147 702 HD patients were analysed in the present study.
Prevalent Dialysis
Outcomes were examined at the end of 2006 using the JSDT 2006 database ID number and other pertinent identifiers to determine the outcome such as death, renal transplantation and withdrawal from the registry. The cause of death was coded with the system of ICD-10. The main causes of death were congestive heart failure, infection, malignancies, stroke, acute myocardial infarction and others. Sudden death including arrhythmia was at~4-6% of the total death in our cohort.
Statistics Data were analysed with SAS/STAT software (version 6.03, SAS Institute Japan, Tokyo, Japan). Student's t-test and the chi-square test were performed to compare the significance of discrete variables. The odds ratio (95% confidence interval) was calculated by a logistic regression procedure using multivariate models with age, sex, laboratory variables and use of anti-hypertensive drugs. A P-value <0.05 were considered significant.
Results
The characteristics of the chronic HD patients studied are summarized in Table 1 . The total number of studied patients was 147 702 (men 50.5%) with a mean (SD) age of 63.6 (12.4)years, and a mean duration of dialysis of 8.0 (6.9)years. Diabetes mellitus (DM) was diagnosed in 31.4% of the total population studied. Mean (SD) pulse rate was 74.6 (12.0)bpm before the HD session. The pulse rate distribution was 0.7% (40-49 bpm), 6.1% (50-59 bpm), 25.3% (60-69 bpm), 38.1% (70-79 bpm), 18.7% (80-89 bpm), 7.9% (90-99 bpm), 2.4% (100-109 bpm) and 0.7% (110-129 bpm). The mean pulse rate was 74.5 bpm in those without past history of acute myocardial infarction (AMI) and 74.2 bpm in those with AMI. The mean pulse rate was 73.8 bpm for those with calcium channel blocker, 73.6 bpm for those with ACEI, 73.7 bpm for ARB, and 73.0 bpm for others. The mean pulse rate decreased as the number of anti-hypertensive drug increased: 75.4 bpm (none), 74.9 bpm (one), 73.9 bpm (two), 72.5 bpm (three) and 72.1 bpm (four), respectively. The prevalence of patients according to the number of antihypertensive drug was distributed as follows: 34.1% (none), 26.7% (one), 24.5% (two), 12.3% (three) and 2.3% (four).
The distribution of the number of patients according to pre-HD pulse rate is shown in Figure 2 . The median pre-HD pulse rate was 74 bpm. Pre-HD pulse rate, bpm Number of patients Fig. 2 . Distribution of patients by pre-dialysis pulse rate. Patients with a low pulse rate of <40 bpm (n = 64) and those with a pulse rate of 130 bpm and over (n = 188) were excluded from the study because of the small fraction to the total number of subjects. Bpm, beats per minute.
The characteristics between those with a pulse rate of 40-69 bpm and those with a pulse rate of 70-129 bpm are compared in Table 2 . Patients with a higher pre-HD pulse rate were more likely to have DM and hypertension, but less likely to be taking an anti-hypertensive medication. Patients with a pre-HD pulse rate of 60-69 bpm were used for comparison (reference).
The number of deaths was 9758 (6.6% of the studied patients) at the end of 2006. The mortality risk based on a pre-HD pulse rate of 70-79 bpm was lowest (5.9%), and the mortality risk increased with an increase in the pulse rate ( Table 3 ). The mortality rate was highest in those with a pre-HD pulse rate of 110-129 bpm (11.0%). The mortality rate was also high in those with a pre-HD pulse rate of 40-49 bpm (8.7%) and 50-59 bpm (7.1%). There was a small fraction of patients with a pre-HD pulse rate of < 40 (n = 64) and >130 (n = 188). The mortality rate was 18.5% and 5.3%, respectively.
After adjusting for multiple variables such as age, sex, duration of dialysis, DM, systolic blood pressure, body mass index, serum albumin, haemoglobin, history of acute myocardial infarction, and anti-hypertensives, the odds ratios (95% confidence interval) of death were significantly higher in those with a pre-HD pulse rate of 70 bpm and over ( Figure 3) . The significance of a lower pre-HD pulse rate of 40-49 and 50-59 bpm disappeared after multivariate adjustment. The causes of death are summarized in Table 4 . Cardiovascular death including heart failure, stroke, sudden death and acute myocardial infarction comprised~46.7% of the deaths.
Discussion
To our knowledge, the present study is the first to document the effect of pre-HD pulse rates on survival in HD patients using a large cohort. In a small cohort, a high heart rate of >85 bpm [17] and a decreased variability in heart rate [18] have been shown to be a predictor of survival. Pulse rate was relatively high in our dialysis population. The median pulse rate was 74 bpm in the pre-HD state, and this was higher than that of the screened Japanese subjects [19] . Causes of tachycardia in HD patients are multi-factorial and include autonomic imbalance, sympathetic activation, and reduced vagal tone. Tachycardia is also associated with cardiovascular risk factors and cardiovascular morbidity and mortality [20, 21] . Elevated heart rate is a prognostic indicator in patients with chronic heart failure in the non-dialysis population [20] . In the total co- hort, tachycardia, defined as 90 bpm and over, was detected in 11.0% of the studied population, and the 1-year mortality rate was 9.0%. Heart failure is a common cause of death in chronic dialysis patients and in our cohort (Table 4) . Therefore, patients with tachycardia may have pre-clinical and/or clinical signs of congestive heart failure. Unfortunately, other pertinent information such as the status of cardiac function evaluated by echocardiography or electrocardiogram was not available. Coronary artery disease is common in incident dialysis patients [22] . The burden of potential confounding factors and comorbid conditions, which are common at initiation of HD, may have disappeared in our dialysis population because the mean dialysis duration was 8.0 years, although some patients may develop atherosclerotic lesions with ageing.
Heart rate reduction is associated with a decrease in post-myocardial infarction cardiac deaths and could be a major determinant of the clinical benefit [23] . Benefits of medication and other intervention procedures may, at least partly, be explained by the decrease in pulse rate. In the general population of patients with coronary artery disease and left ventricular systolic dysfunction, the death rate decreases when the heart rate decreases to <70 bpm using ivabradine, a drug that controls heart rate among stable coronary artery disease and left ventricular systolic dysfunction [20, 24] . Consistent with these reports, HD patients prescribed a beta-blocker have better survival [25] .
Survival rate is the best indicator of 'health status' in the dialysis population [26] . In this regard, the target pre-HD pulse rate would be <70 bpm, comparable to that in the general population. Even the target blood pressure level for the HD population is not yet established [27] . The treatment of hypertension in HD population largely follows the current guidelines for the general population [28] . Survival rate is more dependent on nutritional markers than on blood pressure levels [29] . Patients with hypertension have better levels of nutritional markers, such as body mass index, serum creatinine and serum albumin. In our cohort, several markers of nutrition and dialysis prescription were slightly better among those with a high pulse rate (Table 2) .
Dialysis patients often take many other drugs such as phosphate binders, antacids and sleeping pills. Patients Odds ratio who are not compliant with dietary and dialysis regimens tend to require more drugs, leading to a poor prognosis [30] . Recommendations for an optimal class of anti-hypertensive drugs or target blood pressure level are not currently available for HD patients. Some studies have reported a benefit of renin-angiotensin system inhibitors [31, 32] and calcium channel blockers [33] on cardiovascular events, but not on survival. There is no information available regarding the reasons for selecting a particular class of antihypertensive drugs affecting pulse rate. We estimated that the use of beta-blockers was <10% of the total HD population [16] . More studies are needed to construct treatment guidelines for HD patients [34, 35] . We are currently conducting a randomized controlled trial to answer these questions [36] . The present study has several strengths such as (i) the large cohort of HD patients studied, (ii) the high response rate to the pulse rate questionnaire, (iii) the fact that this is the first study to examine the relationship between pulse rate and survival in HD patients, (iv) the mortality rate of 6.6% per year is better than that in other reports [13, 16] , and (v) mean dialysis duration was 8.0 yearsthose who had significant ischaemic heart disease may have died in our cohort. Therefore, an independent effect of a higher pulse rate on mortality could be detected.
There are also some limitations to the present study. Firstly, the JSDT registry data is a cross-sectional database, and therefore, misclassification of pre-HD pulse rate is possible. In JSDT, pulse rate is usually measured in the supine position lying on a bed while preparing for an HD session. Patients at a pre-HD session are often volumeoverloaded and are concerned about the needle puncture; therefore, they may be in a state of sympathetic overdrive. On the other hand, chronic HD patients are well disciplined with regard to a regular HD session and are concerned about blood pressure, weight gain and, probably, pulse rate [37] . Unusual values of such measurements would be confirmed by repeated measurements or be subject to further evaluation. The JSDT data were crosssectional; therefore, misclassification of pre-HD pulse rate would not be neglected. We also could not evaluate the role of atrial fibrillation and arrhythmia. In the Japanese, the prevalence of atrial fibrillation would be similar or lower than that of Americans of 0.95% [38] . Secondly, the database is complete in the sense that all patient records are forwarded voluntarily by all dialysis units in Japan. Blood samples for laboratory tests are usually taken at the first dialysis session of the week in Japan. Values of serum albumin and haemoglobin may be slightly lowered by dilution. The characteristics of Japanese HD patients are reflected quite accurately in the present study. However, we admit that several potential confounders such as serum potassium, pH, smoking, and use of digoxin or pacemaker might influence pre-HD pulse rate. Thirdly, the follow-up period, 1 year in the present study, may not have been long enough to examine the impact of pulse rate on survival. Fourthly, further analyses of the effect of the socio-economics, education, lifestyles and living environment were not available due to the space limitations in the questionnaire.
Conclusions
Based on the JSDT database, the present observational study showed that pre-HD pulse rate is a significant predictor of survival. The causality of this association remains to be determined. Given the high mortality rate due to cardiovascular disease, prospective studies are needed to determine the target pulse rate levels. Further studies to examine the effect of drugs such as beta-blockers in the chronic HD population are warranted. The reasons for the better annual mortality rate of 6.6% remain to be clarified.
